Penn Medicine Receives $13 Million in Stimulus Construction Funds for New Translational Research Center


September 17, 2010

Penn Medicine News Release

The School of Medicine has received close to $13 million in stimulus funds -- the American Recovery and Reinvestment Act (ARRA) of 2009 -- to construct additional research space in the $370 million Translational Research Center (TRC), which is scheduled to open its first phase in early 2011. The TRC grant is part of the $159 million in ARRA funds awarded to Penn Medicine by the National Institutes of Health (NIH) to create or sustain jobs and to provide the infrastructure necessary to make the scientific discoveries that can lead to improved health. "The ARRA award enables Penn Medicine to realize its vision of truly integrating research in fundamental biological mechanisms with clinical care -- the result will be exciting new approaches to understanding and treating a wide spectrum of diseases that are most prevalent in our society, including cancer, diabetes, and atherosclerosis," says Glen N. Gaulton, PhD, Executive Vice Dean and Chief Scientific Officer, who serves as the principal investigator of the TRC grant. Read More

Additional Coverage